Cycloalkylurea derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11352357
APP PUB NO 20220081441A1
SERIAL NO

17526722

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SUMITOMO DAINIPPON PHARMA CO., LTD.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Funakoshi, Yuta Osaka, JP 2 2
Ideue, Eiji Osaka, JP 3 3
Komiya, Masafumi Osaka, JP 4 8
Lee, Shoukou Osaka, JP 3 2
Uesugi, Shunichiro Osaka, JP 6 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 7, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 7, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 7, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00